Efficacy and Toxicity Study of dsAAV-delivered RNAi Therapy
碩士 === 臺灣大學 === 醫學檢驗暨生物技術學研究所 === 95 === Hepatits B virus (HBV) is a major human pathogen that chronically infected over 350 million people worldwide, rendering these patients at high risk of developing liver failure, cirrhosis and hepatocellular carcinoma. Current treatments for chronic HBV are sub...
Main Authors: | Tzu-Hui Wu, 吳姿慧 |
---|---|
Other Authors: | Mi-Hua Tao |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/33308226360368743719 |
Similar Items
-
RNAi efficacy is enhanced by chronic dsRNA feeding in pollen beetle
by: Jonathan Willow, et al.
Published: (2021-04-01) -
Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHD
by: Lindsay M. Wallace, et al.
Published: (2018-03-01) -
Increased RNAi Efficacy in Spodoptera exigua via the Formulation of dsRNA With Guanylated Polymers
by: Olivier Christiaens, et al.
Published: (2018-04-01) -
Extracellular endonucleases in the midgut of Myzus persicae may limit the efficacy of orally delivered RNAi
by: Amol Bharat Ghodke, et al.
Published: (2019-08-01) -
AAV-Mediated CRISPRi and RNAi Based Gene Silencing in Mouse Hippocampal Neurons
by: Matthias Deutsch, et al.
Published: (2021-02-01)